Healthcare Finance News February 9, 2024
Jeff Lagasse

Optum Rx is working with Calibrate to bring its medication management strategy to employers seeking GLP-1 covered benefits.

Rob MacNaughton has been named new chief executive officer of Calibrate, a clinician-guided, value-based obesity treatment program, and one of his first missions will be to solidify a relationship with Optum Rx as a strategic partner during the company’s enterprise-first growth phase.

MacNaughton assumes the role of CEO at Calibrate at a time when the company is pushing growth in enterprise clients. Enter Optum Rx, one the country’s largest pharmacy benefits managers (PBMs). Optum Rx is working with Calibrate to bring its cost-effective medication management strategy to employers seeking GLP-1 covered benefits.

In August 2023, Calibrate launched the program for one of...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Employer, Partnerships, Pharma, Pharma / Biotech, Trends
AI, patient data firms aim to speed up drug development
HHS files brief in 340B rebate model case: 4 takeaways
Latigo raises $150M to get non-opioid pain drugs through key tests
AstraZeneca Aims to Make Cell Therapy More Accessible With $425M EsoBiotec Acquisition
CMS doubles down on Medicare drug price negotiations

Share This Article